| 000 -LEADER |
|---|
| fixed length control field |
06355nam a22004455i 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20140310150254.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
130321s2013 ne | s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9789400762626 |
|
978-94-007-6262-6 |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RC261-271 |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
614.5999 |
| Edition number |
23 |
| 264 #1 - |
|---|
| -- |
Dordrecht : |
| -- |
Springer Netherlands : |
| -- |
Imprint: Springer, |
| -- |
2013. |
| 912 ## - |
|---|
| -- |
ZDB-2-SBL |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Hayat, M.A. |
| Relator term |
editor. |
| 245 10 - IMMEDIATE SOURCE OF ACQUISITION NOTE |
|---|
| Title |
Stem Cells and Cancer Stem Cells, Volume 10 |
| Medium |
[electronic resource] : |
| Remainder of title |
Therapeutic Applications in Disease and Injury / |
| Statement of responsibility, etc |
edited by M.A. Hayat. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
XLII, 298 p. 35 illus., 28 illus. in color. |
| Other physical details |
online resource. |
| 440 1# - SERIES STATEMENT/ADDED ENTRY--TITLE |
|---|
| Title |
Stem Cells and Cancer Stem Cells ; |
| Volume number/sequential designation |
10 |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Prelims -- I Mesenchymal stem cells -- Mesenchymal stem cells in bone regeneration -- Experimental (preclinical) studies and clinical trials of adipose tissue-derived mesenchymal stem cells for Autoimmune diseases -- Validity of markers for epithelial cells and mesenchymal Cells -- Mesenchymal stem cell survival in infarcted myocardium: adhesion and anti-death signals -- Hepatogenic differentiation: comparison between adipose tissue -derived stem cells and bone marrow mesenchymal stem cells -- Fibrin for encapsulation of human mesenchymal stem cells for chondrogenic differentiation -- Differences between adipose tissue-derived mesenchymal stem cells and bone marrow-derived mesenchymal stem cells as regulators of the immune response -- Transforming growth factor-beta induced chrondrogenic differentiation of bone marrow-derived mesenchymal stem cells: role of smad signaling pathways -- II Induced pluripotent stem cells -- Drug discovery using human ipsc based disease models and functional hepatic cells -- Generation of antigen-specific t lymphocytes from induced pluripotent stem cells for adoptive immunotherapy -- III Neural cells and neural stem cells -- Genetic identification of human embryonic stem cell-derived neural cell types using bacterial artificial chromosomes -- Moderate low temperature preserves the stemness of neural stem cells (methods) -- IV Role of stem cells in disease -- High-dose chemotherapy with autologous stem cell support in the treatment of transformed b-cell non-hodgkin's lymphomas -- The wnt/β-catenin pathway as a potential target for drug Resistant leukemic stem cells -- Bone marrow stem cell therapies for diabetes mellitus and its complications -- Thyroid cancer stem cells – strategies for therapeutic targeting.- Role of cancer stem cell in mammary carcinogenesis and its clinical implication -- Critical analysis of parkinson’s disease models and cell-based therapy -- Presence of an early lineage stem cell phenotype in meningioma-initiating cells -- Isolation and characterization of cancer stem cells from dog glioblastoma -- Role of stem cell niche in the development of bone metastases (an update) -- Treatment of hemophilia a using b cell-directed protein delivery.-V Stem cell transplantation -- Reduction in the risk invasive fungal infection relapse in patients undergoing allogenic stem cell transplantation using caspofunginas secondary prophylaxis -- Hematopoietic stem cell transplantation in elderly patients with myelodisplastic syndrome and acute myelogenous leukemia: use of busulfan/fludarabine for conditioning -- Co-transplantation of islets with mesenychymal stem cells improves islet revascularization and reversal of hyperglycemia -- Significance of interleukin -7 receptor alpha polymorphisms in allogeneic stem cell transplantation -- Index. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
Presenting contributions by 66 experts representing 13 countries, Volume 10 of the series Stem Cells and Cancer Stem Cells synthesizes current understanding of the causes, diagnosis, and therapy of major human diseases and debilitating tissue and organ injuries, using cell-based treatment. This volume presents contemporary research into generation, preservation, and uses of stem cells in fighting disease and tissue/organ injuries. The contents of the volume are organized into five sections. Mesenchymal Stem Cells section includes chapters on the use of stem cells in bone regeneration, studies and trials of stem cells in autoimmune diseases, and differences between adipose tissue-derived mesenchymal stem cells and bone marrow-derived mesenchymal stem cells as regulators of immune response. Induced Pluripotent Stem Cells section offers chapters on drug discovery using human IPSC-based disease models, and on generation of antigen-specific lymphocytes from IPSCs. Neural Cells and Neural Stem Cells section discusses use of bacterial artificial chromosomes in the genetic identification of stem cell-derived neural cell types, and use of moderate low temperature to preserve the stemness of neural stem cells. The section, Role of Stem Cells in Disease, discusses stem cell support in high-dose chemotherapy of Non-Hodgkin’s Lymphomas; potential targets for drug resistant leukemic stem cells, bone marrow stem cell therapies for diabetes mellitus. This section also discusses the use of stem cells in treating thyroid, breast and bone cancers, hempophilia and Parkinson’s Disease. The section, Stem Cell Transplantation, includes chapters on reducing fungal infection in allogenic stem cell transplantation patients, use of Bulsufan/Fludarabine for conditioning in haematopoietic stem cell transplantation, and interleukin-7 receptor alpha polymorphisms in allogeneic stem cell transplantation. The editor, M.A. Hayat, is a Distinguished Professor in the Department of Biological Sciences at Kean University, Union, New Jersey, USA. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Medicine. |
|
|---|
| Topical term or geographic name as entry element |
Science (General). |
|
|---|
| Topical term or geographic name as entry element |
Oncology. |
|
|---|
| Topical term or geographic name as entry element |
Biomedicine. |
|
|---|
| Topical term or geographic name as entry element |
Cancer Research. |
|
|---|
| Topical term or geographic name as entry element |
Oncology. |
|
|---|
| Topical term or geographic name as entry element |
Medicine/Public Health, general. |
|
|---|
| Topical term or geographic name as entry element |
Science, general. |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY |
|---|
| Title |
Springer eBooks |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
|---|
| Display text |
Printed edition: |
| International Standard Book Number |
9789400762619 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
http://dx.doi.org/10.1007/978-94-007-6262-6 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Item type |
E-Book |
